257 related articles for article (PubMed ID: 30717372)
1. Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.
Fabian D; Guillermo Prieto Eibl MDP; Alnahhas I; Sebastian N; Giglio P; Puduvalli V; Gonzalez J; Palmer JD
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717372
[TBL] [Abstract][Full Text] [Related]
2. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
Zhu P; Zhu JJ
Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
[TBL] [Abstract][Full Text] [Related]
3. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
[TBL] [Abstract][Full Text] [Related]
4. Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.
Majd P; O'Connell DE; Kim RC; Bota DA; Carrillo JA
CNS Oncol; 2017 Apr; 6(2):89-94. PubMed ID: 28303729
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy.
Saria MG; Kesari S
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S9-S13. PubMed ID: 27668388
[TBL] [Abstract][Full Text] [Related]
6. Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients.
Mehta M; Wen P; Nishikawa R; Reardon D; Peters K
Crit Rev Oncol Hematol; 2017 Mar; 111():60-65. PubMed ID: 28259296
[TBL] [Abstract][Full Text] [Related]
7. Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.
McClelland S; Sosanya O; Mitin T; Degnin C; Chen Y; Attia A; Suh JH; Jaboin JJ
J Neurooncol; 2018 Oct; 140(1):155-158. PubMed ID: 29987746
[TBL] [Abstract][Full Text] [Related]
8. Tumor Treating Fields Utilization in a Glioblastoma Patient with a Preexisting Cardiac Pacemaker: The First Reported Case.
McClelland S; Henrikson CA; Ciporen JN; Jaboin JJ; Mitin T
World Neurosurg; 2018 Nov; 119():58-60. PubMed ID: 30064027
[TBL] [Abstract][Full Text] [Related]
9. The Value of Tumor Treating Fields in Glioblastoma.
Zhang C; Du J; Xu W; Huang H; Gao L
J Korean Neurosurg Soc; 2020 Nov; 63(6):681-688. PubMed ID: 32380584
[TBL] [Abstract][Full Text] [Related]
10. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
[TBL] [Abstract][Full Text] [Related]
11. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
Zhu P; Du XL; Lu G; Zhu JJ
Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
[TBL] [Abstract][Full Text] [Related]
13. Tumour treating fields in a combinational therapeutic approach.
Branter J; Basu S; Smith S
Oncotarget; 2018 Nov; 9(93):36631-36644. PubMed ID: 30564303
[TBL] [Abstract][Full Text] [Related]
14. Tumor Treating Fields in Neuro-Oncological Practice.
Mrugala MM; Ruzevick J; Zlomanczuk P; Lukas RV
Curr Oncol Rep; 2017 Aug; 19(8):53. PubMed ID: 28664468
[TBL] [Abstract][Full Text] [Related]
15. Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme.
Mirza FA; Shamim MS
J Pak Med Assoc; 2018 Oct; 68(10):1543-1545. PubMed ID: 30317361
[TBL] [Abstract][Full Text] [Related]
16. Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune
Kinzel A; Ambrogi M; Varshaver M; Kirson ED
Clin Med Insights Oncol; 2019; 13():1179554918825449. PubMed ID: 30728735
[TBL] [Abstract][Full Text] [Related]
17. First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: a case report.
O'Connell D; Shen V; Loudon W; Bota DA
CNS Oncol; 2017 Jan; 6(1):11-18. PubMed ID: 27918194
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction.
Mallick S; Gandhi AK; Rath GK
Indian J Med Paediatr Oncol; 2015; 36(4):229-37. PubMed ID: 26811592
[TBL] [Abstract][Full Text] [Related]
19. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
